SARAH OVERMYER: Open Payments
NPI 1346695145 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 41 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $262 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 7 | $309 |
| Madrigal Pharmaceuticals | 10 | $256 |
| Verona Pharma, Inc. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Lilly USA, LLC | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Shockwave Medical, Inc | 1 | $27 |
Products named: Indigo System, REZDIFFRA, Ohtuvayre, ENTYVIO, DUPIXENT, TREMFYA, ZEPBOUND, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter.
Industry payments across KY — which companies pay providers there.
